Lifecore Biomedical Inc (NAS:LFCR)
$ 4.72 -0.010 (-0.21%) Market Cap: 178.67 Mil Enterprise Value: 316.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 57/100

Q1 2026 Lifecore Biomedical Inc Earnings Call Transcript

May 06, 2026 / 12:00PM GMT
Release Date Price: $4.96 (-3.88%)
Operator

Good morning, and thank you for joining Lifecore's earnings call for the first quarter ended March 31, 2026. (Operator Instructions)

Now I would like to turn the call over to Stephanie Diaz, Manager of Investor Relations for Lifecore.

Stephanie Diaz
Lifecore Biomedical Inc - Investor Relations

Good morning, and thank you for joining us. Today, Lifecore Biomedical will provide its earnings for the first quarter ended March 31, 2026, and corporate update. As the company has recently changed its fiscal year-end to align with the calendar year, we will be comparing our results for the first quarter ended March 31, 2026, with the comparable prior year quarter ended February 23, 2025. Hosting the call today from Lifecore are Paul Josephs, President and Chief Executive Officer; and Ryan Lake, Chief Financial Officer. Before we begin, I'd like to remind everyone that today's conference call will contain forward-looking statements. It is important to note that the forward-looking statements made during this call reflect management's judgment and analysis only

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot